Most of PrEP’s side effects are relatively mild and dissipate within a few months. However, these drugs can come with rare but serious risks.
Two patients have reportedly been cured of the HIV (human immunodeficiency virus) through bone marrow transplants intended to treat their…
This month, more than 50 patients have filed lawsuits against the California-based drug company, alleging that Gilead Sciences has prioritized…
A new single-dose flu drug known as baloxavir marboxil has received priority review from the FDA. According to the drug’s…
Older people using certain antidepressants are at an increased risk of developing bronchiectasis, a condition where the airways in the…
Genvoya, a new anti-HIV drug that could drastically reduce long-term side effects, was given European Commission approval, allowing 28 countries…
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
Symptoms & Concerns
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward